News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,152 Results
Type
Article (35067)
Company Profile (266)
Press Release (664814)
Multimedia
Podcasts (136)
Webinars (24)
Section
Business (229871)
Career Advice (2144)
Deals (36890)
Drug Delivery (193)
Drug Development (79114)
Employer Resources (164)
FDA (15889)
Job Trends (14854)
News (337044)
Policy (29295)
Tag
2025 Best Places to Work (21)
2026 Best Places to Work (32)
2027 BioCapital Standard (3)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (1358)
Academic (1)
Accelerated approval (67)
ADA (45)
Adcomms (26)
Allergies (214)
Alliances (47775)
ALS (274)
Alzheimer's disease (1946)
Antibody-drug conjugate (ADC) (729)
Approvals (16547)
Artificial intelligence (928)
ASCO (317)
Autoimmune disease (510)
Automation (70)
Bankruptcy (384)
Belgium (44)
Best Places to Work (10811)
BIO (80)
Biologics (113)
BIOSECURE Act (23)
Biosimilars (282)
BioSpace Insights (108)
Biotechnology (179)
Bispecific (59)
Bladder cancer (214)
Brain cancer (89)
Breast cancer (858)
Cancer (7193)
Cardiovascular disease (604)
Career advice (1830)
Career pathing (56)
CAR-T (414)
CDC (32)
CDMO (209)
Celiac Disease (6)
Cell therapy (1131)
Cervical cancer (59)
Clinical research (71607)
Collaboration (2690)
Commercialization (71)
Company closure (9)
Compensation (1904)
Complete response letters (119)
COVID-19 (2373)
CRISPR (136)
CRO (7)
C-suite (1666)
Cystic fibrosis (169)
Data (10577)
Decentralized trials (4)
Denatured (15)
Depression (210)
Dermatology (181)
Diabetes (732)
Diagnostics (7260)
Digital health (78)
Diversity (7)
Diversity, equity & inclusion (38)
Drug discovery (461)
Drug pricing (214)
Drug shortages (30)
Duchenne muscular dystrophy (363)
Earnings (91488)
Editorial (72)
Employer branding (24)
Employer resources (152)
ESMO (407)
Events (121295)
Executive appointments (1329)
Eye disease (24)
FDA (20692)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (27)
Frontotemporal dementia (42)
Funding (2158)
Gene editing (284)
Generative AI (83)
Gene therapy (867)
GLP-1 (1224)
Government (3233)
Grass and pollen (8)
Guidances (416)
Healthcare (16460)
Hematology (201)
HIV (107)
Huntington's disease (89)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (150)
Immunology and inflammation (380)
Immuno-oncology (156)
Indications (282)
Infectious disease (2778)
Inflammatory bowel disease (255)
Inflation Reduction Act (13)
Influenza (150)
Intellectual property (384)
Interviews (440)
IPO (17455)
IRA (50)
Job creations (4250)
Job search strategy (1461)
JPM (62)
Kidney cancer (29)
Kidney disease (165)
Labor market (126)
Layoffs (695)
Leadership (58)
Legal (7370)
Licensing (131)
Liver cancer (111)
Longevity (47)
Lung cancer (981)
Lung diease (23)
Lymphoma (514)
Machine learning (69)
Management (64)
Manufacturing (1526)
Marketing (41)
MASH (247)
Medical affairs (6)
Medical device (14346)
Medtech (14679)
Mergers & acquisitions (20976)
Metabolic disorders (1916)
Middle East (2)
mRNA (304)
Multiple sclerosis (250)
Multispecific (5)
NASH (19)
Netherlands (40)
Neurodegenerative disease (593)
Neuropsychiatric disorders (144)
Neuroscience (3997)
Neurotech (3)
NextGen: Class of 2026 (5872)
Non-profit (1953)
Now hiring (101)
Obesity (900)
Opinion (353)
Ovarian cancer (277)
Pain (325)
Pancreatic cancer (435)
Parkinson's disease (455)
Partnered (40)
Patents (785)
Patient advocacy (2)
Patient recruitment (961)
Patient selection (119)
Peanut (77)
People (60395)
Peptides (43)
Pharmaceutical (59)
Pharmacy benefit managers (38)
Phase 1 (22494)
Phase 2 (31951)
Phase 3 (23697)
Pipeline (14157)
Policy (332)
Postmarket research (1962)
Preclinical (9096)
Press Release (65)
Prostate cancer (375)
Psychedelics (93)
Radioligand (2)
Radiopharmaceuticals (433)
Rare diseases (1446)
Real estate (5849)
Recruiting (72)
Regenerative medicine (36)
Regulatory (25600)
Reports (65)
Research institute (1357)
Resumes & cover letters (336)
Rett syndrome (52)
RNA editing (32)
RSV (95)
Saudi Arabia (1)
Schizophrenia (214)
Series A (401)
Series B (283)
Service/supplier (10)
Sickle cell disease (137)
Special edition (36)
Spinal muscular atrophy (176)
Sponsored (35)
Startups (4000)
State (2)
Stem cells (6)
Stomach cancer (21)
Substance use disorders (22)
Supply chain (152)
Switzerland (23)
Tariffs (103)
Tax incentives (1)
The Weekly (119)
Vaccines (1185)
Venture capital (172)
Weight loss (578)
Wet AMD (7)
Women's health (161)
Women in leadership (1)
Worklife (26)
Date
Today (118)
Last 7 days (813)
Last 30 days (3782)
Last 365 days (31452)
2026 (28667)
2025 (30372)
2024 (35194)
2023 (40341)
2022 (50734)
2021 (54087)
2020 (50997)
2019 (41929)
2018 (32050)
2017 (32486)
2016 (30661)
2015 (36100)
2014 (28949)
2013 (23943)
2012 (25541)
2011 (25694)
2010 (23657)
Location
Africa (706)
Alabama (116)
Alaska (6)
Arizona (355)
Arkansas (14)
Asia (45108)
Australia (7271)
California (16694)
Canada (4555)
China (1993)
Colorado (720)
Connecticut (745)
Delaware (462)
Europe (95742)
Florida (2469)
Georgia (524)
Hawaii (4)
Idaho (60)
Illinois (1178)
India (153)
Indiana (765)
Iowa (34)
Japan (756)
Kansas (142)
Kentucky (61)
Louisiana (47)
Maine (90)
Maryland (1725)
Massachusetts (12100)
Michigan (424)
Minnesota (901)
Mississippi (6)
Missouri (170)
Montana (36)
Nebraska (27)
Nevada (200)
New Hampshire (88)
New Jersey (4408)
New Mexico (35)
New York (4184)
North Carolina (2118)
North Dakota (12)
Northern California (8717)
Ohio (449)
Oklahoma (25)
Oregon (45)
Pennsylvania (3160)
Puerto Rico (36)
Rhode Island (62)
South America (1084)
South Carolina (100)
South Dakota (1)
Southern California (6603)
Tennessee (237)
Texas (2680)
United States (57768)
Utah (489)
Vermont (2)
Virginia (380)
Washington D.C. (74)
Washington State (1300)
West Virginia (4)
Wisconsin (170)
Wyoming (5)
700,152 Results for "eisai company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Kidney cancer
Merck, Eisai’s Keytruda triplet fails to improve survival in kidney cancer
A triplet regimen comprising Merck’s Welireg and PD-1 blockbuster Keytruda and Eisai’s Lenvima flopped in a Phase 3 renal cell carcinoma trial.
April 21, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Eisai and Linus Health Launch New Online Resource to Help Adults Explore Their Brain Health
November 12, 2026
·
5 min read
Press Releases
Faron Pharmaceuticals LTD: Holding(s) in Company - November 17, 2026
November 17, 2026
·
3 min read
Press Releases
Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026
October 15, 2026
·
29 min read
Alzheimer’s disease
Biogen, Eisai hit with 3-month delay for starting SubQ Alzheimer’s therapy
The FDA’s extension will give reviewers more time to review a major amendment to Biogen and Eisai’s application for a subcutaneous induction formulation of Alzheimer’s therapy Leqembi. The new target action date is on Aug. 24.
May 8, 2026
·
2 min read
·
Tristan Manalac
Series A
Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs
With programs from Eisai and Hansoh Pharmaceutical in hand, Tortugas Neuroscience has emerged with hopes of delivering daily oral treatments to patients with central nervous system conditions.
April 21, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Eisai to Present New Five-Year Lecanemab Data and Real-World Alzheimer’s Disease Research at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
October 29, 2026
·
10 min read
Press Releases
Karyopharm Therapeutics Inc. Announces Planned Merger with Ayrmid Ltd. to Strengthen Company for the Future
November 2, 2026
·
10 min read
Press Releases
AVS Bio, an Arlington Capital Partners Portfolio Company, Acquires Biorbyt Ltd.
September 23, 2026
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company - September 7, 2026
September 7, 2026
·
3 min read
1 of 70,016
Next